| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Pharmaceutical And Medicine Manufacturing
| News Release June 2, 2014-Pediapharm is the only Canadian specialty pharmaceutical company dedicated to serving the needs of the pediatric community. Its mission is to bring to the Canadian market the latest innovative pediatric products with the objective to improve the health and the well-being of children in Canada. Since its debut in 2008, Pediapharm has entered into numerous commercial agreements with partners from Canada and other countries around the world. The company's innovative product portfolio includes NYDA?; a breakthrough treatment for head lice; EpiCeram? a non-steroid emulsion for eczema; KoolEffect? which reduces the symptoms of fever; and VapoLyptus?; a soothing vapour patch of Eucalyptus and Camphor.
|
|
| *Capital Pool Company
| Seeking QT primarily in these sectors: Unknown
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *MDP | *Medexus Pharmaceuticals Inc. | TSX Venture | DELIST |
| *MDP.DB | *Medexus Pharmaceuticals Inc. db16oct2023 | TSX Venture | DELIST |
| *MDP.WT | *Medexus Pharmaceuticals Inc. wt. 23Feb2023 | TSX Venture | DELIST |
| *PDP | *Pediapharm Inc. | TSX Venture | DELIST |
| *CAV.P | *Chelsea Acquisition Corporation | TSX Venture | DELIST |
|
|
| Name History | From | To |
| *Medexus Pharmaceuticals Inc. | 19/Dec/2018 | 16/Jun/2021 |
| *Pediapharm Inc. | 27/Dec/2013 | 18/Dec/2018 |
| *Chelsea Acquisition Corporation | 25/Nov/2011 | 26/Dec/2013 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
